U.S. Red Biotechnology Market Size & Outlook, 2025-2030

Name: U.S. Red Biotechnology Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The red biotechnology market in the United States is expected to reach a projected revenue of US$ 248,963.1 million by 2030. A compound annual growth rate of 6% is expected of the United States red biotechnology market from 2025 to 2030.

U.S. red biotechnology product outlook (Revenue, USD million, 2018-2030)
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Proteins
- Vaccines
- Cell-Based Immunotherapy Products
- Gene Therapy Products
- Cell Therapy Products
- Tissue-Engineered Products
- Stem Cells
- Cell Culture
- Viral Vector
- Enzymes
- Kits and Reagents
- Animal Models
- Molecular Diagnostics
- Others
U.S. red biotechnology end-user outlook (Revenue, USD million, 2018-2030)
- Academic Research Institutes
- CMOs & CROs
- Pharmaceutical & Biotechnology Companies
- Others

U.S. Red Biotechnology Market Size & Outlook, 2025-2030

Sign up - it's easy, and free!